U2AF 结合多嘧啶束位点的微卫星不稳定性会扰乱结直肠癌发生过程中的选择性剪接。
Microsatellite instability at U2AF-binding polypyrimidic tract sites perturbs alternative splicing during colorectal cancer initiation.
发表日期:2024 Aug 06
作者:
Vincent Jonchère, Hugo Montémont, Enora Le Scanf, Aurélie Siret, Quentin Letourneur, Emmanuel Tubacher, Christophe Battail, Assane Fall, Karim Labreche, Victor Renault, Toky Ratovomanana, Olivier Buhard, Ariane Jolly, Philippe Le Rouzic, Cody Feys, Emmanuelle Despras, Habib Zouali, Rémy Nicolle, Pascale Cervera, Magali Svrcek, Pierre Bourgoin, Hélène Blanché, Anne Boland, Jérémie Lefèvre, Yann Parc, Mehdi Touat, Franck Bielle, Danielle Arzur, Gwennina Cueff, Catherine Le Jossic-Corcos, Gaël Quéré, Gwendal Dujardin, Marc Blondel, Cédric Le Maréchal, Romain Cohen, Thierry André, Florence Coulet, Pierre de la Grange, Aurélien de Reyniès, Jean-François Fléjou, Florence Renaud, Agusti Alentorn, Laurent Corcos, Jean-François Deleuze, Ada Collura, Alex Duval
来源:
GENOME BIOLOGY
摘要:
错配修复缺陷 (dMMR) 导致的微卫星不稳定性 (MSI) 在结直肠癌 (CRC) 中很常见。这些癌症与体细胞编码事件相关,但这种基因组不稳定性的非编码病理生理学影响尚不清楚。在这里,我们使用全外显子组测序对结直肠肿瘤发生的不同步骤的编码和非编码 MSI 事件进行分析,并通过大肿瘤和单细胞水平的 RNA 测序搜索相关的剪接事件。我们的结果表明 MSI 导致数百个非编码 DNA 突变,尤其是在剪接中具有顺式活性的聚嘧啶 U2AF RNA 结合位点,而与非 MSI CRC 相比,在 MSI 的 mRNA 中观察到外显子跳跃事件的频率更高。在 DNA 水平上,这些非编码 MSI 突变在 dMMR 结肠隐窝中的细胞转化之前很早就发生,仅占 MSI CRC 中外显子跳跃的一小部分。在RNA水平上,异常的外显子跳跃特征可能会损害MSI CRC中的结肠细胞分化,影响编码控制细胞命运的蛋白质亚型的替代外显子的表达,同时还靶向组成型外显子,使dMMR细胞在疾病发生前的早期阶段具有免疫原性。编码突变。该特征的特点是与在其他几种非 MSI 癌症中观察到的致癌 U2AF1-S34F 剪接突变相似。总体而言,这些发现提供了证据,表明部分由 MSI 驱动的非常早期的 RNA 剪接特征会损害细胞分化并促进 MSI CRC 起始,远早于编码突变,这些突变随后在 MSI 肿瘤发生过程中积累。© 2024。作者。
Microsatellite instability (MSI) due to mismatch repair deficiency (dMMR) is common in colorectal cancer (CRC). These cancers are associated with somatic coding events, but the noncoding pathophysiological impact of this genomic instability is yet poorly understood. Here, we perform an analysis of coding and noncoding MSI events at the different steps of colorectal tumorigenesis using whole exome sequencing and search for associated splicing events via RNA sequencing at the bulk-tumor and single-cell levels.Our results demonstrate that MSI leads to hundreds of noncoding DNA mutations, notably at polypyrimidine U2AF RNA-binding sites which are endowed with cis-activity in splicing, while higher frequency of exon skipping events are observed in the mRNAs of MSI compared to non-MSI CRC. At the DNA level, these noncoding MSI mutations occur very early prior to cell transformation in the dMMR colonic crypt, accounting for only a fraction of the exon skipping in MSI CRC. At the RNA level, the aberrant exon skipping signature is likely to impair colonic cell differentiation in MSI CRC affecting the expression of alternative exons encoding protein isoforms governing cell fate, while also targeting constitutive exons, making dMMR cells immunogenic in early stage before the onset of coding mutations. This signature is characterized by its similarity to the oncogenic U2AF1-S34F splicing mutation observed in several other non-MSI cancer.Overall, these findings provide evidence that a very early RNA splicing signature partly driven by MSI impairs cell differentiation and promotes MSI CRC initiation, far before coding mutations which accumulate later during MSI tumorigenesis.© 2024. The Author(s).